Roche (RHHBY), Ascletis, Inc. to Collaborate on Hepatitis C Drugs for China
4/15/2013
More...
|
GlaxoSmithKline (GSK) Targets "Electroceuticals" for Potential New Therapies
4/11/2013
More...
|
GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical Engineering and Sciences to Develop New Medicines for Emerging Markets
4/9/2013
More...
|
Resverlogix Corporation (RVX.TO) to Spin-Out RVX Therapeutics Inc. (RVX)
4/8/2013
More...
|
Roche (RHHBY) and Isis Pharmaceuticals, Inc. (ISIS) Form $392 Million Alliance for Huntington's Disease
4/8/2013
More...
|
AstraZeneca PLC (AZN) Shells Out $240 Million Upfront for Moderna Therapeutics mRNA Drugs
3/22/2013
More...
|
bluebird bio Forms Cancer Drug Partnership With Celgene Corporation (CELG)
3/21/2013
More...
|
Receptos Licenses AbbVie (ABBV) Antibody for Co-Development
3/14/2013
More...
|
Astellas Pharma Inc. (YPH.BE) and Ambit Biosciences to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
3/13/2013
More...
|
Presage Biosciences Snags $13 Million From Celgene Corporation (CELG) to Pick Winning Cancer Drug Combos
3/5/2013
More...
|
Merck & Co., Inc. (MRK) and Samsung Corporation to Develop Biosimilar Drugs Together
2/20/2013
More...
|
Roche (RHHBY) and Chiasma Inc. to Ally on Drug Development for Up to $600 Million
2/20/2013
More...
|
RQx Pharmaceuticals, Inc. Inks $111 Million Genentech (RHHBY) Deal
2/12/2013
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) to Buy Elan Corporation PLC (ELN)'s Tysabri Rights for $3.25 Billion
2/7/2013
More...
|
The Medicines Company (MDCO) Buys Cholesterol Drug Rights From Alnylam Pharmaceuticals (ALNY) for Up to $205 Million
2/5/2013
More...
|
Allergan Inc. (AGN) to Buy MAP Pharmaceuticals, Inc. (MAPP) for $958 Million
1/23/2013
More...
|
Life Technologies (LIFE) Gains on Buyout Speculation
1/21/2013
More...
|
Shire plc (SHPG) Rises on AstraZeneca PLC (AZN) Bid Talk: Traders
1/17/2013
More...
|
MacroGenics, Inc.'s DART Platform Grabs Potential $1 Billion Gilead Sciences, Inc. (GILD) Deal
1/8/2013
More...
|
Amgen (AMGN), BIND Biosciences, Inc. Ink $180 Million Tumor Treatment Deal
1/8/2013
More...
|
Gilead Sciences, Inc. (GILD) Bags Blood Disorder Drug With $510 Million YM BioSciences (YM.TO) Buy
12/13/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Enters $376 Million Deal for Xenon Pharmaceuticals Inc. Pain Drug
12/11/2012
More...
|
Amgen (AMGN) Bags Gene-Hunting Firm deCODE genetics, Inc. (DCGN) for $415 Million Cash
12/11/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB), Isis Pharmaceuticals, Inc. (ISIS) in Drug Development Pact for Up to $630 Million
12/10/2012
More...
|
Sanofi (France) (SAN.PA) Deal Could Net Selecta Biosciences, Inc. $900 Million
11/29/2012
More...
|
Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK) Team Up to Form Clinical Trial Site Database
11/15/2012
More...
|
Forest Laboratories, Inc. (FRX) and Adamas Pharmaceuticals Form Alliance for Up to $160 Million
11/14/2012
More...
|
Foundation Medicine and AstraZeneca PLC (AZN) Announce Genomic Profiling Collaboration
11/12/2012
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Shells Out $140 Million for Envoy Therapeutics
11/6/2012
More...
|
Amgen (AMGN) Closes Deal With Financial Firm to Open New Biotech Company Atara Biotherapeutics
10/29/2012
More...
|
Pfizer Inc. (PFE) Will Buy NextWave Pharmaceuticals for Up to $680 Million
10/23/2012
More...
|
Theravance, Inc. (THRX), Merck & Co., Inc. (MRK) Ink $153 Million Cardiovascular Pact
10/16/2012
More...
|
Merck & Co., Inc. (MRK), AiCuris Ink $571 Million CMV Pact
10/16/2012
More...
|
AstraZeneca PLC (AZN) Boosts Pipeline With $272 Million Ardelyx Inc. Drug Deal
10/9/2012
More...
|
Evotec AG (EVTG.F) and Bayer AG (BAY.F) Enter Into $765 Million Multi-Target Alliance to Fight Endometriosis
10/1/2012
More...
|
MacroGenics, Inc. Could Earn More Than $1 Billion Through New Servier Alliance
9/20/2012
More...
|
Baxter International, Inc. (BAX) and Onconova Therapeutics Inc. Announce European Licensing Agreement for Up to $515 Million
9/19/2012
More...
|
Complete Genomics, Inc. to be Bought by Chinese Firm for $117.6 Million
9/17/2012
More...
|
AstraZeneca PLC (AZN)'s MedImmune (AZN) Forms Chinese Joint Venture for Biologic Drug
9/11/2012
More...
|
Genmab A/S (GEN.CO) Inks $1.1 Billion Deal With Johnson & Johnson (JNJ)
8/31/2012
More...
|
Allergan Inc. (AGN), Molecular Partners AG Ink $1.5 Billion Exclusive Pact
8/21/2012
More...
|
AstraZeneca PLC (AZN) Buys Into Regulus Therapeutics, Inc.' MicroRNA Therapeutics for $28 Million
8/15/2012
More...
|
Elan Corporation PLC (ELN) Fuels Buyout Plans With $130 Million R&D Spinout, Unit Will Have Around 80 Staffers
8/14/2012
More...
|
S*Bio of Singapore Sells Cancer Drug Rights to MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) for $75 Million
8/10/2012
More...
|
GlaxoSmithKline (GSK) Completes $3.6 Billion Takeover of Human Genome Sciences, Inc. (HGSI)
8/6/2012
More...
|
Life Technologies (LIFE) Buys Navigenics for Genetic Diagnostics
7/17/2012
More...
|
GlaxoSmithKline (GSK) Clinches Deal to Buy Human Genome Sciences, Inc. (HGSI) for $2.8 Billion
7/16/2012
More...
|
Alnylam Pharmaceuticals (ALNY), Ascletis, Inc. Create Strategic Collaboration to Develop ALN-VSP
7/12/2012
More...
|
Verastem, Inc. (VSTM) Buys Pfizer Inc. (PFE) Cancer Drug Candidate in Deal Worth $126.5 Million
7/12/2012
More...
|
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY) Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc. (AMLN)
7/3/2012
More...
|
AstraZeneca PLC (AZN), Rigel Pharmaceuticals, Inc. (RIGL) Strike Potential $100 Million Asthma Drug Deal
6/19/2012
More...
|
Roche (RHHBY)'s Genentech (RHHBY) Grabs Alzheimer's Drug Rights From AC Immune SA for $418 Million-Plus
6/19/2012
More...
|
GlaxoSmithKline (GSK) Rumored to be Buying $5 Billion BioMarin Pharmaceutical Inc. (BMRN)
6/13/2012
More...
|
GlaxoSmithKline (GSK) Pays $227 Million for Basilea Pharmaceutica (BSLN.SW) Eczema Drug
6/12/2012
More...
|
AstraZeneca PLC (AZN) Bids $4 Billion for Diabetes Specialist Amylin Pharmaceuticals, Inc. (AMLN)
6/5/2012
More...
|
Basilea Pharmaceutica (BSLN.SW) Participates in Public-private Collaboration to Tackle Antibiotic Resistance
5/25/2012
More...
|
Agilent Technologies Inc. (A) to Acquire Dako North America, Inc. for $2.2 Billion
5/17/2012
More...
|
GlaxoSmithKline (GSK)'s $2.6 Billion Bid for Human Genome Sciences, Inc. (HGSI) Goes Hostile
5/10/2012
More...
|
Novartis AG (NVS) Snags Fougera (AAA) for $1.5 Billion for Generic Skin Drugs
5/3/2012
More...
|
Axerion Therapeutics Inc., AstraZeneca PLC (AZN) Inks Pact to Combat Alzheimer's Disease
5/2/2012
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Explores Sale, Hires Bankers: Sources; Is AstraZeneca PLC (AZN) Interested?
4/24/2012
More...
|
AstraZeneca PLC (AZN) to Acquire Ardea Biosciences, Inc. for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout
4/23/2012
More...
|
Human Genome Sciences, Inc. (HGSI) Rejects GlaxoSmithKline (GSK)'s $2.6 Billion Bid, Seeks Higher Offers
4/20/2012
More...
|
Roche (RHHBY) Ready to Walk Away From $6.8 Billion Illumina, Inc. (ILMN) Bid
4/19/2012
More...
|
Amgen (AMGN) to Pay $315 Million for Privately-Held KAI Pharmaceuticals, Inc.
4/11/2012
More...
|
Watson Pharmaceuticals, Inc. (WPI) Close to $7 Billion Actavis Drug Deal: Sources
3/22/2012
More...
|
Heptares Grants Shire plc an Exclusive Worldwide $190 Million License to Develop and Commercialise Novel Drug Candidate for CNS Disorders
3/20/2012
More...
|
BioCon Limited (BIOCON.NS) Plunges After Pfizer Inc. (PFE) Scraps $350 Million Insulin Pact
3/14/2012
More...
|
EpiStem Ltd Announces a Three Year Collaboration With GlaxoSmithKline (GSK) in Fibrosis Research
3/13/2012
More...
|
Mersana Therapeutics, Inc. Strikes $270 Million Antibody-drug Conjugate Deal With Endo Pharmaceuticals (ENDP)
3/7/2012
More...
|
AngioChem, GlaxoSmithKline (GSK) Form $331 Million Pact to Discover and Develop Treatments of Lysosomal Storage Diseases
2/27/2012
More...
|
Enanta Pharmaceuticals, Inc. Strikes Hep C Drug Deal With Novartis AG (NVS) Worth Up to $440 Million
2/22/2012
More...
|
Pfizer Inc. (PFE) Eyes Tie-Ups With More Chinese Drugmakers; Will Ally With Zhejiang Hisun to Invest $545 Million in Generic Drug JV
2/21/2012
More...
|
Roche (RHHBY) Digs in for Long Fight as Illumina, Inc. (ILMN) Rejects $5.7 Billion Bid
2/10/2012
More...
|
Merck KGaA (MKGAF.PK) Signs $550 Million Cancer Pact With Threshold Pharmaceuticals, Inc. (THLD)
2/3/2012
More...
|
Genentech (RHHBY) Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms
1/17/2012
More...
|
Roche (RHHBY) Signs $646 Million Pain Pact With Xenon Pharmaceuticals Inc.
1/10/2012
More...
|
Bristol-Myers Squibb Company (BMY) to Acquire Inhibitex, Inc. (INHX) for $2.5 Billion
1/9/2012
More...
|
FORMA Therapeutics, Inc. Cuts $815 Million Deal With Boehringer Ingelheim Corporation to Discover Cancer Drugs
1/5/2012
More...
|
Alexion Pharmaceuticals Inc. (ALXN) to Pay $1 Billion for Enobia Pharma
12/29/2011
More...
|
Pharmacyclics, Inc. (PCYC) Could Get $975 Million in Johnson & Johnson (JNJ) License Deal
12/9/2011
More...
|
AstraZeneca PLC (AZN) Digs Deeper in China With Generics Buy
12/8/2011
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Teams With Samsung Corporation on $300 Million Biosimilar Venture
12/6/2011
More...
|
MacroGenics, Inc. Inks Pharma Deal With Servier Worth Up to $450 Million
12/1/2011
More...
|
Roche (RHHBY) and PTC Therapeutics, Inc. Sign $490 Million Deal for Genetic Disease Program
11/29/2011
More...
|
Gilead Sciences, Inc. (GILD) to Acquire Pharmasset, Inc. (VRUS) for $11 Billion
11/22/2011
More...
|
AMAG Pharmaceuticals, Inc. (AMAG) Hires Jefferies and Co. to Explore Sale
11/17/2011
More...
|
Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ)'s Tibotec Pharmaceuticals Ltd to Create Combination HIV Therapy
11/16/2011
More...
|
Lundbeck Inc. Pays Otsuka Pharmaceutical Co., Ltd. $200 Million Upfront in CNS Drug Deal, Complete Deal is Worth $1.8 Billion if Milestones are Met
11/14/2011
More...
|
Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) End Bydureon Pact; Amylin to Make $1.45 Billion in Payments
11/8/2011
More...
|
Abbott Laboratories (ABT) to Split Into 2 Companies
10/21/2011
More...
|
GlaxoSmithKline (GSK) May Make $4.8 Billion Bid for Human Genome Sciences, Inc. (HGSI): Source
10/19/2011
More...
|
Roche (RHHBY) Buys Anadys Pharmaceuticals, Inc. (ANDS) for $230 Million to Boost Hepatitis Ops
10/17/2011
More...
|
GlycoMimetics, Inc. Inks Licensing Deal Worth Up to $340 Million with Pfizer Inc. (PFE)
10/11/2011
More...
|
PPD, Inc. (PPDI) to be Acquired by The Carlyle Group and Hellman & Friedman for $3.9 Billion
10/4/2011
More...
|
Bristol-Myers Squibb Company (BMY) and Ambrx, Inc. Announce $24 Million Collaboration for Novel Biologics Programs in Diabetes and Heart Failure
9/22/2011
More...
|
Roche (RHHBY), Evotec AG (EVTG.F) Sign Alzheimer's Pact Worth Up to $830 Million
9/7/2011
More...
|
f-Star, Merck Serono Sign $708 Million Deal for Antibody-Derived Therapeutics
9/7/2011
More...
|
Astellas Pharma Inc. (YPH.BE), Evec Team Up for Antibody Pact Worth Up to $176.8 Million
9/6/2011
More...
|
Sanofi (France) (SASY.PA) Strikes Deal With Pfizer Inc. (PFE) to Make Generic Lipitor
9/1/2011
More...
|
Carlyle Group in Talks to Buy PPD, Inc. (PPDI) for as Much as $4.3 Billion
8/17/2011
More...
|
QIAGEN N.V. (QGEN) and Pfizer Inc. (PFE) Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer
8/16/2011
More...
|
4-Antibody AG Forms Collaboration with Human Genome Sciences, Inc. (HGSI)
8/16/2011
More...
|
AMAG Pharmaceuticals, Inc. (AMAG) Investor MSMB Makes $378 Million Takeover Bid for Firm to Stop Merger With Allos Therapeutics, Inc. (ALTH)
8/3/2011
More...
|
Bristol-Myers Squibb Company (BMY) to Pay Up to $475 Million for Amira Pharmaceuticals, Inc., Scoops Up Lung Drug
7/22/2011
More...
|
Novartis AG Ends Pursuit of Gen-Probe Incorporated (GPRO)
7/22/2011
More...
|
AMAG Pharmaceuticals, Inc. (AMAG), Allos Therapeutics, Inc. (ALTH) to Merge in $686 Million Deal
7/20/2011
More...
|
Micromet Inks Cancer Drug Deal With Amgen (AMGN) Worth Up to $1.01 Billion
7/12/2011
More...
|
Bristol-Myers Squibb Company (BMY), Innate Pharma (IPH.PA ) Announce $465 Million Deal for an Investigational Immuno-Oncology Biologic; Innate to Receive $35 Million Upfront, Shares Soar
7/7/2011
More...
|
Vertex Pharmaceuticals (MA) (VRTX) in Licensing Pact Potentially Worth $1.5 Billion With Alios BioPharma to Expand Hepatitis Pipeline
6/13/2011
More...
|
Merck & Co., Inc. (MRK) Buys Hanwha Drug-Marketing Rights for $720 Million
6/13/2011
More...
|
Merck & Co., Inc. (MRK), Roche (RHHBY) Pair Up on Tests for Cancer Treatments
6/7/2011
More...
|
Clovis Oncology (CLVS) Receives License for Worldwide Development and Commercialization Rights to Pfizer Inc. (PFE)'s Oral and IV PARP Inhibitor PF-01367338
6/3/2011
More...
|
AVEO Pharmaceuticals, Inc. (AVEO) Enters into Worldwide License Agreement with Centocor Ortho Biotech Products, L.P.; AVEO Receives $15 Million; Eligible for up to $540 Million
5/31/2011
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Nails Nycomed Buyout for $13.7 Billion, Skin Unit to Spin Off
5/19/2011
More...
|
Allos Therapeutics, Inc. (ALTH) and Mundipharma AG Announce Strategic Collaboration for FOLOTYN; Allos to Receive $50 Million Upfront; Potentially up to $310.5 Million
5/11/2011
More...
|
Alkermes (ALKS), Elan Drug Technologies in $960 Million Merger
5/9/2011
More...
|
Teva Pharmaceutical Industries Limited (TEVA) to Buy Japanese Generic Drugmaker, Taiyo Pharmaceuticals Industry Co. Ltd. for $490 Million
5/3/2011
More...
|
Teva Pharmaceutical Industries Limited (TEVA) to Buy Cephalon, Inc. (CEPH) for Over $6 Billion, Tops Valeant Pharmaceuticals International (VRX)
5/2/2011
More...
|
Sanofi-Aventis (Canada) Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
4/18/2011
More...
|
Exelixis, Inc. (EXEL) Said to Hire Goldman, Sachs & Co. to Field Possible Takeover Approaches; Shares Rise on Speculation
4/12/2011
More...
|
Zacharon Pharmaceuticals, Inc. Announces Potential $200 Million Collaboration With Pfizer Inc. (PFE) to Develop Drugs for Multiple Rare Disorders
4/7/2011
More...
|
Cephalon, Inc. (CEPH) Spurns Valeant Pharmaceuticals International (VRX)'s $5.7 Billion Hostile Bid as Too Low
4/6/2011
More...
|
Merck & Co., Inc. (MRK) to Acquire Inspiration Biopharmaceuticals for $430 Million
4/6/2011
More...
|
Seattle Genetics, Inc. (SGEN) Announces Antibody-Drug Conjugate Collaboration with Abbott Laboratories (ABT); Seattle Genetics Gets $8 Million Upfront; Eligible for as much as $200 Million
3/22/2011
More...
|
Cephalon, Inc. (CEPH) to Acquire Gemin X Pharmaceuticals, Inc. for $225 Million; up to $300 Million in Milestones
3/22/2011
More...
|
FivePrime Therapeutics, Inc. Nabs $495M Deal With Human Genome Sciences, Inc. (HGSI) to Develop Cancer Drug
3/17/2011
More...
|
Research Unit Going to China, Pfizer Inc. (PFE) Says; Company Plans Gradual Move of Antibacterials Operations to Shanghai
3/16/2011
More...
|
Daiichi Sankyo, Inc. (D4S.F) to Acquire Plexxikon Inc. for $805 Million Upfront, Approval of PLX4032 Could Bring in an Additional $130 Million
3/1/2011
More...
|
Sanofi-Aventis (France) (SASY.PA) to Buy Genzyme Corporation (GENZ) for Over $20 Billion; Most Genzyme Jobs Safe
2/17/2011
More...
|
Astellas Pharma Inc. (YPH.BE) to Pay AVEO Pharmaceuticals, Inc. (AVEO) as Much as $1.3 Billion for Kidney Cancer Medicine; AVEO to Get $125M Upfront
2/17/2011
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Signs Definitive Agreement to Acquire SynthRx, Inc.
2/14/2011
More...
|
Danaher to Buy Beckman Coulter, Inc. (BEC) for $6.8 Billion
2/9/2011
More...
|
Optimer Pharmaceuticals, Inc. (OPTR), Astellas Pharma Inc. (YPH.BE) Sign Collaboration For Antibiotic Fidaxomicin; Optimer Eligible to Receive Milestone Payments of up to $224 Million Including $68 Million Upfront Cash Payment
2/7/2011
More...
|
Genoptix, Inc. Announces Agreement to be Acquired by Novartis Corporation (NVS) for $470 Million
1/25/2011
More...
|
Theraclone Sciences, Inc. and Pfizer Inc. (PFE) Enter into Infectious Disease and Cancer Antibody Discovery Collaboration; Pfizer to Pay up to $632M
1/19/2011
More...
|
Eli Lilly and Company (LLY) and Boehringer Ingelheim Corporation Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide; Boehringer Ingelheim to Get 300M Euro; up to a Total of 625M Euro
1/12/2011
More...
|
Bristol-Myers Squibb Company (BMY) and Pharmasset, Inc. (VRUS) Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C
1/10/2011
More...
|
Seattle Genetics, Inc. (SGEN), Pfizer Inc. (PFE) in $208 Million Antibody Tech Deal
1/7/2011
More...
|
As Deadline Nears, Suitor Genzyme Corporation (GENZ) May Have to Revise Bid For Sanofi-Aventis K.K.
12/10/2010
More...
|
Johnson & Johnson (JNJ) Launches $2.3 Billion Bid for Crucell N.V. (CRXL)
12/8/2010
More...
|
Dicerna Pharmaceuticals Expands Pact Kyowa Hakko Kirin; Original Agreement Worth $1.4 Billion Potentially
12/7/2010
More...
|
GE Healthcare and Johnson & Johnson (JNJ)'s Janssen Pharmaceutica N.V. Deal Pairs Two Alzheimer's Powerhouses
12/3/2010
More...
|
Merck & Co., Inc. (MRK) to Buy SmartCells, Inc. in Deal Worth Possibly $500 Million
12/2/2010
More...
|
GlaxoSmithKline (GSK) to Buy $129.4M in Theravance, Inc. (THRX) Stock
11/30/2010
More...
|
Amgen (AMGN) Said to Consider Actelion Ltd. (ALIOF.PK) Takeover Bid to Gain Rare Disease Drugs
11/17/2010
More...
|
Genzyme Corporation (GENZ) in Talks to Sell Itself to Takeda Pharmaceutical Co. Ltd. (TKDG.DE) for $18.5 Billion
11/15/2010
More...
|
Clavis Pharma ASA and Clovis Oncology Sign New $205 Million Deal For Pancreatic Cancer Drug in Asia And Rest of World
11/11/2010
More...
|
Eli Lilly and Company (LLY) to Acquire Avid Radiopharmaceuticals, Inc. in $800 Million Deal
11/9/2010
More...
|
McKesson Corporation Pays $2 Billion To Buy US Oncology, Inc.
11/2/2010
More...
|
BioCon Limited, Pfizer Inc. (PFE) In Potential $350 Million Insulin Licensing Deal
10/19/2010
More...
|
UCB SA And Synosia Therapeutics Sign Parkinson's Disease Alliance Worth $745 Million Potentially
10/12/2010
More...
|
ImmunoGen, Inc. (IMGN) Signs Cancer Treatment Deal With Novartis AG; Immunogen to Receive $45 Million Upfront With Potential for $200 Million
10/12/2010
More...
|
Pfizer Inc. (PFE) To Buy King Pharmaceuticals®, Inc. For $3.6 Billion Cash
10/12/2010
More...
|
Exelixis, Inc. (EXEL) Licenses Two Drug Programs To Bristol-Myers Squibb Company (BMY); Exelixis Nabs $60M Upfront, Potentially $505M More
10/11/2010
More...
|
Johnson & Johnson (JNJ) Aims to Buy Vaccine Maker Crucell N.V. (CRXL) for 1.75 Billion Euros ($2.3 Billion)
9/17/2010
More...
|
Genzyme Corporation (GENZ) to Sell Genetics Unit to Laboratory Corporation of America Holdings (LabCorp) (LH) for $925 Million; Genzyme Cutting 1,000 Jobs Over Next 15 Months
9/14/2010
More...
|
Roche (RHHBY), reMYND Sign $637M Early-Stage Parkinson, Alzheimer Deal
9/8/2010
More...
|
Bristol-Myers Squibb Company (BMY) to Acquire ZymoGenetics, Inc. (ZGEN) For $885 Million
9/8/2010
More...
|
Onyx Pharmaceuticals, Inc. (ONXX) Licenses to Ono Pharmaceutical Company, Ltd. Japanese Rights to Cancer Drug For More Than $300 Million
9/8/2010
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) And Orexigen Therapeutics, Inc. (OREX) Sign $1 Billion Obesity Pact
9/3/2010
More...
|
Quark Pharmaceuticals Inc., Novartis Corporation (NVS) Sign $670-Mln Drug Deal
8/19/2010
More...
|
Any Sanofi-Aventis (France) (SASY.PA) Deal For Genzyme Corporation (GENZ) May Take Time, At Limited Price
8/19/2010
More...
|
Life Technologies (LIFE) To Buy DNA Sequencing Company, Ion Torrent Systems, Inc. For $375 Mln
8/18/2010
More...
|
Alectos Therapeutics Announces Collaboration With Merck & Co., Inc. (MRK) to Develop Drugs for Alzheimer's Disease; Alectos Therapeutics Could Receive $289 Million
8/11/2010
More...
|
GlaxoSmithKline (GSK) and Amplimmune Form Global Strategic Collaboration; GSK to Pay Amplimmune $23 Million Upfront; Deal Worth up to $485 Million
8/4/2010
More...
|
Conatus Pharmaceuticals Inc. Buys Back Idun Pharmaceuticals, Inc. From Pfizer Inc. (PFE)
8/2/2010
More...
|
Sanofi-Aventis (France) (SASY.PA), GlaxoSmithKline (GSK) Eyes Troubled Genzyme Corporation (GENZ); Genzyme Rebuffs Sanofi Bid
7/28/2010
More...
|
Mylan Inc. (MYL) To Buy Bioniche Pharma USA LLC For $550 Mln
7/15/2010
More...
|
Genentech (RHHBY) Nabs License to MRC Technology's CNS Disease Candidates
7/12/2010
More...
|
Infinity Pharmaceuticals Inc. (INFI) and Intellikine, Inc. Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma; Intellikine To Receive $13.5 Million Initially In Deal Valued Up to $488 Million
7/8/2010
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Picks Japan's Eisai Inc. (ESALF.PK) To Market Obesity Drug Lorcaserin In Deal Worth $1.3 Billion Potentially
7/1/2010
More...
|
Celgene (CELG) to Buy Abraxis BioScience, Inc. for $2.9 Billion
6/30/2010
More...
|
Gilead Sciences, Inc. (GILD) to Acquire CGI Pharmaceuticals, Inc. for Up to $120 Million
6/25/2010
More...
|
Sanofi-Aventis (France) (SASY.PA) and Regulus Therapeutics, Inc. Form Major Strategic Alliance, Largest microRNA Therapeutics Alliance to Date, Valued at Potentially Over $750 Million
6/22/2010
More...
|
Biovail Corporation (BVF), Valeant Pharmaceuticals International (VRX) in $3.2B Reverse Merger; Valeant Shareholders to Get $16.77/Share Special Dividend
6/21/2010
More...
|
Bayer Schering Pharma and OncoMed Pharmaceuticals, Inc. Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics; OncoMed to Get $40 Million Upfront; up to $387.5 Million
6/17/2010
More...
|
Abbott Laboratories (ABT), Neurocrine Biosciences, Inc. (NBIX) in Pact for Endometriosis Drug, Elagolix; Neurocrine to Get up to $575 Million
6/16/2010
More...
|
Forest Laboratories, Inc. (FRX) and TransTech Pharma, Inc. Enter Into License Agreement for the Development and Commercialization of Glucokinase Activators; Deal Valued at Up to $1.105 Billion
6/8/2010
More...
|
Grifols in Friendly $3.4 Billion Takeover of Talecris Biotherapeutics (TLCR)
6/7/2010
More...
|
Abbott Laboratories (ABT) Buys Piramal Healthcare Limited Biz for $3.72B
5/21/2010
More...
|
Astellas Pharma Inc. Buys OSI Pharmaceuticals, Inc. (OSIP) for $4 Billion in Cancer Push
5/17/2010
More...
|
Pfizer Inc. (PFE) Enters Into Agreement With ErgoNex Pharma GmbH to Acquire Investigational Treatment for Pulmonary Arterial Hypertension
5/12/2010
More...
|
Evotec AG (EVTG.F) Enters Into Integrated Drug Discovery Alliance With Genentech (RHHBY)
5/10/2010
More...
|
Genzyme Corporation (GENZ) OKs $2B Buyback, Company to Shed Three Extraneous Units
5/7/2010
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Says Partner Merck & Co., Inc. (MRK) to Acquire Cancer Treatment; Ariad to Receive $50 Million Upfront Payment and up to $514 Million
5/5/2010
More...
|
Glenmark Pharmaceuticals, Sanofi (France) (SAN.PA) in $345 Million Drug-Licensing Pact
5/3/2010
More...
|
Array BioPharma, Inc. (ARRY) Inks $467 Million Deal with Novartis AG
4/20/2010
More...
|
Astellas Pharma Inc.: Won't Raise OSI Pharmaceuticals, Inc. (OSIP) Bid on FDA Move Alone
4/19/2010
More...
|
Hospira, Inc. (HSP) and Javelin Pharmaceuticals (JAV) Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin for Approximately $145 Million
4/19/2010
More...
|
Elan Corporation PLC (ELN) Mulls Spinning Off Drug Delivery Unit to Create Two Publicly Listed Companies
4/19/2010
More...
|
Celgene (CELG) and Agios Pharmaceuticals Announce Global Strategic Collaboration to Advance Unique Science of Cancer Metabolism; Agios Will Receive $130 Million Upfront
4/15/2010
More...
|
GlaxoSmithKline (GSK), Isis Pharmaceuticals, Inc. (ISIS) in Drug Development Deal of up to $1.5 Billion
4/1/2010
More...
|
AMAG Pharmaceuticals, Inc. (AMAG) Enters into Anemia Drug Licensing Deal with Takeda Pharmaceutical Co. Ltd. (TKDG.DE); AMAG to Get $60 Million Upfront, Eligible for $220 Million in Milestone Payments
4/1/2010
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Reaches Deal with Icahn; Avoids Proxy Fight
3/22/2010
More...
|
GlaxoSmithKline (GSK) Up as Novartis Corporation (NVS) Drops Generic Advair in U.S.; Novartis Hands Back U.S. Rights to VR315 to Vectura Limited
3/18/2010
More...
|
Teva Pharmaceutical Industries Limited (TEVA) to Acquire Ratiopharm for Nearly $5 Billion
3/18/2010
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Board Rejects Astellas Pharma Inc. (JOBS) $3.5 Billion Bid
3/15/2010
More...
|
Novartis Corporation (NVS) Takes Option on TRANSGENE (TRGNY) Cancer Vaccine; Transgene Gets $10 Million, Milestones Could Reach $950 Million
3/10/2010
More...
|
Abbott Laboratories (ABT) (JOBS) to Buy Facet Biotech (JOBS) for $722 Million
3/10/2010
More...
|